2024
DOI: 10.1039/d4fd00023d
|View full text |Cite
|
Sign up to set email alerts
|

An engineered T7 RNA polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis

Mathew Miller,
Oscar Alvizo,
Scott Baskerville
et al.

Abstract: Messenger RNA (mRNA) therapies have recently gained tremendous traction with the approval of mRNA vaccines for the prevention of SARS-CoV-2 infection. However, manufacturing challenges have complicated large scale mRNA production,...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
2

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…The malachite green assay kit (MAK307, Sigma-Aldrich) was purchased and used according to the manufacturer's protocol. A series of phosphate standard solutions with final concentrations of 40,32,24,16,12,8,4, and 0 μM, containing malachite green, were prepared, and their absorbance was measured at 644 nm. The protein crude product, prepared using the previously described recipe, was diluted to fall within the appropriate measurement range, and its absorbance was measured.…”
Section: Generation Of Egfp and 4-mu Calibration Curvesmentioning
confidence: 99%
See 1 more Smart Citation
“…The malachite green assay kit (MAK307, Sigma-Aldrich) was purchased and used according to the manufacturer's protocol. A series of phosphate standard solutions with final concentrations of 40,32,24,16,12,8,4, and 0 μM, containing malachite green, were prepared, and their absorbance was measured at 644 nm. The protein crude product, prepared using the previously described recipe, was diluted to fall within the appropriate measurement range, and its absorbance was measured.…”
Section: Generation Of Egfp and 4-mu Calibration Curvesmentioning
confidence: 99%
“…as engineered lipases and proteases for detergents, novel catalysts for bioremediation and green chemistry, and degradative enzymes for cellulosic biofuels [1][2][3][4][5][6][7][8][9][10] ) and medicine (e.g. as targets for drugs used to treat cancer [11][12][13][14][15][16] and infectious disease [17][18][19][20][21] , as catalysts for efficient synthesis of pharmaceuticals [22][23][24][25] , and as therapeutics in metabolic flux disorders [26][27][28][29] ). Despite impressive and rapid progress in the ability to design protein sequences that reliably adopt desired low-energy structures, designing enzymes with specified activities, specificities, and catalytic efficiencies remains an unsolved challenge.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, there is still a lack of dened concentration limits that are established by the regulatory agencies for dsRNA. 3 From a reaction optimisation perspective, multiple approaches have been followed to reduce dsRNA such as engineering T7 RNA polymerase, 13,14 or blocking the 3 0 end with complementary oligonucleotides to avoid overextension. 15 New chromatographic modalities can be applied, exploring physicochemical differences between mRNA and dsRNA.…”
Section: Introductionmentioning
confidence: 99%